• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Biophys J . Elucidation of Interactions Regulating Conformational Stability and Dynamics of SARS-CoV-2 S-Protein

tetano

Editor, Senior Moderator
Biophys J


. 2021 Jan 20;S0006-3495(21)00049-7.
doi: 10.1016/j.bpj.2021.01.012. Online ahead of print.
Elucidation of Interactions Regulating Conformational Stability and Dynamics of SARS-CoV-2 S-Protein


Takaharu Mori[SUP] 1 [/SUP], Jaewoon Jung[SUP] 2 [/SUP], Chigusa Kobayashi[SUP] 3 [/SUP], Hisham M Dokainish[SUP] 1 [/SUP], Suyong Re[SUP] 4 [/SUP], Yuji Sugita[SUP] 5 [/SUP]



Affiliations

Abstract

Ongoing COVID-19 pandemic caused by new coronavirus, SARS-CoV-2, calls for urgent developments of vaccines and antiviral drugs. The spike protein of SARS-CoV-2 (S-protein), which consists of trimeric polypeptide chains with glycosylated residues on the surface, triggers the virus entry into a host cell. Extensive structural and functional studies on this protein have rapidly advanced our understanding of the S-protein structure at atomic resolutions, while most of structural studies overlook the effect of glycans attached to S-protein on the conformational stability and functional motions between the inactive Down and the active Up forms. Here, we performed all-atom molecular dynamics (MD) simulations of both Down and Up forms of a fully glycosylated S-protein in solution as well as targeted MD (TMD) simulations between them to elucidate key inter-domain interactions for stabilizing each form and inducing the large-scale conformational transitions. The residue-level interaction analysis of the simulation trajectories detects distinct amino-acid residues and N-glycans as determinants on conformational stability of each form. During the conformational transitions between them, inter-domain interactions mediated by glycosylated residues are switched to play key roles on the stabilization of another form. Electrostatic interactions as well as hydrogen bonds between the three receptor binding domains work as driving forces to initiate the conformational transitions toward the active form. This study sheds light on the mechanisms underlying conformational stability and functional motions of S-protein, which are relevant for vaccines and antiviral drugs developments.
 
Back
Top Bottom